Abstract:Objective To evaluate the inhibitory effect and the possible mechanism of rhendostatin (rhES) on nasopharyngeal carcinoma cells (CNE2). Methods CNE2 cells were treated with rhES of different concentrations(25, 50, 100, 200 and 400 μg /ml, respectively) in vitro. Methyl thiazolyl tetrazolium (MTT) assay was used for detecting the cell proliferation in rhES treatment at different concentrations and different time intervals. Flow cytometry was used for detecting the effect of rhES on cell cycle and apoptosis. Transmission electron microscope was used for observing the cellular morphology of CNE2 cells. Results ① MTT detection showed that rhES significantly inhibited the growth of nasopharyngeal carcinoma cell CNE2 in both time and dosedependent manners. 72 hours after rhES treatment it was at 400 μg/ml, and the inhibitory rate was 41.89%, which was higher than those of the other groups. ② Flow cytometry showed that the proportion of CNE2 cells arrested in G0/G1 phase and cell apoptosis rate after rhES treatment were significantly higher than those of the control group respectively (P<0.05). ③ Transmission electron microscope identified the characteristics of apoptosis appeared in CNE2 cell of rhES group, such as crenation of cell organ, chips of chromatin margination and disappearance of caryotheca. Conclusion By inducing apoptosis and changing the cell cycle distribution, rhES can inhibit the proliferation of nasopharyngeal carcinoma cell CNE2 in both time and dosedependent manners.